Minerva Neurosciences, Inc. (NERV) — Financial statements
Income statement, balance sheet, and cash flow for Minerva Neurosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 6↓51.6% | 12↓6.3% | 13↓13.3% | 15↓54.3% | 32 | |
| General & Administrative Expenses | 9↓6.1% | 10↓4.5% | 10↓1.6% | 11↓20.6% | 13 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 9↓6.1% | 10↓4.5% | 10↓1.6% | 11↓20.6% | 13 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 15↓30.9% | 22↓5.5% | 23↓8.4% | 25↓44.4% | 45 | |
| Total Costs & Expenses | 15↓30.9% | 22↓5.5% | 23↓8.4% | 25↓44.4% | 45 | |
| Operating Results | ||||||
| Operating Income | -15↑30.9% | -22↑5.5% | -23↑8.4% | -25↑44.4% | -45 | |
| Depreciation & Amortization | 0.01↓75.8% | 0.02↓27.5% | 0.03↑263.9% | 0.01↓91.6% | 0.10 | |
| EBITDA | -293↓4971.2% | 6↑127.8% | -22↑12.2% | -25↑45.5% | -45 | |
| EBIT | -293↓4989.5% | 6↑127.6% | -22↑12.1% | -25↑45.6% | -45 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -3↑51.9% | -7↑0.1% | -7↓8.5% | -6 | |
| Interest Income | 0.00↓100.0% | 1↓11.5% | 1↑158.0% | 0.56↑3272.2% | 0.02 | |
| Interest Expense | 0.00↓100.0% | 5↓44.9% | 8↑11.8% | 7↑17.1% | 6 | |
| Non-Operating Income | 278↑1099.4% | -28↓1893.3% | -1↓164.0% | -0.53↓3340.7% | 0.02 | |
| Other Income / Expenses | -278↓1295.2% | 23↑438.2% | -7↓0.1% | -7↓8.4% | -6 | |
| Income Before Tax | -293↓20492.7% | 1↑104.8% | -30↑6.6% | -32↑37.9% | -52 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -293↓20492.7% | 1↑104.8% | -30↑6.6% | -32↑35.7% | -50 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -293↓20492.7% | 1↑104.8% | -30↑6.6% | -32↑35.7% | -50 | |
| Bottom-Line Net Income | -293↓20492.7% | 1↑104.8% | -30↑6.6% | -32↑35.7% | -50 | |
| EPS (Basic) | -34.67↓18347.4% | 0.19↑104.1% | -4.61↑23.3% | -6.01↑35.7% | -9.35 | |
| EPS (Diluted) | -34.67↓18347.4% | 0.19↑104.1% | -4.61↑23.3% | -6.01↑35.7% | -9.35 | |
| Weighted Average Shares | 8↑11.8% | 8↑16.3% | 7↑21.8% | 5↑0.0% | 5 | |
| Weighted Average Diluted Shares | 8↑11.8% | 8↑16.4% | 7↑21.8% | 5↑0.0% | 5 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.